MONTI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.886
EU - Europa 2.258
AS - Asia 1.069
SA - Sud America 168
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 6.403
Nazione #
US - Stati Uniti d'America 2.840
IT - Italia 1.047
SG - Singapore 340
DE - Germania 325
UA - Ucraina 268
CN - Cina 249
SE - Svezia 166
BR - Brasile 149
HK - Hong Kong 141
VN - Vietnam 131
TR - Turchia 115
FI - Finlandia 98
IE - Irlanda 82
GB - Regno Unito 73
RU - Federazione Russa 73
FR - Francia 25
IN - India 22
JP - Giappone 22
ES - Italia 21
MX - Messico 21
CA - Canada 17
BE - Belgio 16
NL - Olanda 16
BG - Bulgaria 11
PL - Polonia 10
ZA - Sudafrica 8
BD - Bangladesh 7
CZ - Repubblica Ceca 6
AR - Argentina 5
AT - Austria 5
LT - Lituania 5
MY - Malesia 5
SA - Arabia Saudita 5
VE - Venezuela 5
UZ - Uzbekistan 4
AU - Australia 3
EU - Europa 3
PH - Filippine 3
PT - Portogallo 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
GE - Georgia 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
NP - Nepal 2
PY - Paraguay 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.403
Città #
Milan 605
Chandler 271
Fairfield 229
Ashburn 217
Jacksonville 206
Singapore 205
Woodbridge 162
Ann Arbor 145
Hong Kong 138
Houston 131
Como 126
Beijing 115
Dallas 109
Seattle 100
Wilmington 93
New York 89
Nyköping 87
Dearborn 86
Dublin 82
Princeton 78
Cambridge 77
Boardman 69
Los Angeles 61
Izmir 60
Rome 50
Munich 46
The Dalles 40
Dong Ket 32
São Paulo 27
San Mateo 25
Ogden 23
Chicago 20
Helsinki 17
Buffalo 16
Orem 16
San Diego 16
Turku 16
Brussels 15
London 15
Tokyo 15
Frankfurt am Main 14
Ponte Lambro 14
Casorezzo 13
Ho Chi Minh City 13
Atlanta 12
Denver 12
Gallarate 12
Hanoi 12
Kunming 12
Santa Clara 12
Varese 12
Chennai 10
Ankara 9
Hefei 9
Montreal 9
Poplar 9
Redmond 9
Warsaw 9
Bulgorello 8
Düsseldorf 8
Querétaro 8
Amsterdam 7
Barcelona 7
Des Moines 7
Johannesburg 7
Mexico City 7
San Francisco 7
Shenyang 7
Sofia 7
Washington 7
Berlin 6
Boston 6
Salt Lake City 6
Shanghai 6
Brooklyn 5
Charlotte 5
Edinburgh 5
Falkenstein 5
Falls Church 5
Guangzhou 5
Hebei 5
Mumbai 5
Nanjing 5
Norwalk 5
Nuremberg 5
Rozzano 5
Stockholm 5
Verona 5
Bournemouth 4
Brno 4
Lappeenranta 4
Magnago 4
Miami 4
Paris 4
Phoenix 4
Redwood City 4
St Petersburg 4
Zhengzhou 4
Belo Horizonte 3
Chiba 3
Totale 4.359
Nome #
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis 273
AIF-1 and RNASET2 Play Complementary Roles in the Innate Immune Response of Medicinal Leech 258
In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6. 221
Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase 219
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells 213
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 207
Biochemical and immunohistochemical characterization of human RNASET2 expression 204
Intracellular trafficking of RNASET2, a novel component of P-bodies 182
A hedgehog homolog is involved in muscle formation and organization of Sepia officinalis (mollusca) mantle. 179
DYSREGULATED EXPRESSION OF ANKYRIN REPEAT DOMAIN 1 IN THE DEVELOPING MYOCARDIUM CAUSES ANOMALOUS VENOUS RETURN AND MORPHOGENETIC DEFECTS BY IMPAIRING CARDIAC REMODELLING 179
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene 170
Muscle development and differentiation in the urodele Ambystoma mexicanum. 162
TLR2 expression in medicinal leech 162
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 162
Ribonuclease T2 (RNASET2) expression in the spectrum of neuroendocrine neoplasms of the lung. Relationships with hypoxia-related mechanisms and microvascular patterns 155
Cellular and biochemical characterization of the human member of Rh/T2/S ribonucleases 154
RNASET2 - An autoantigen in anaplastic large cell lymphoma identified by protein array analysis. 153
AIF-1 and RNASET2 play different roles in the modulation of leech innate immune response 151
Antimicrobial role of RNASET2 protein during innate immune response in the medicinal leech Hirudo verbana 150
Common fragile site FRA6E spans at least 7,5 Mb 149
Human RNASET2 as a candidate stress-response gene involved in non-cell autonomous tumor suppression. 146
The human RNASET2 tumor antagonizing gene as a novel stress-response gene potentially involved in microenvironment-mediated tumor suppression 146
DIFFERENT BUT COMPLEMENTARY ROLES OF RNASET2 AND AIF-1 IN THE MODULATION OF MEDICINAL LEECHES INNATE IMMUNE RESPONSE 144
Prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6 142
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells 138
The pleiotropic roles of the human RNASET2 tumor suppressor gene 137
Mutant alleles in Aicardi-Goutieres syndrome patients produce a disfunctional RNASET2 protein associated with alterations in interferon signalling. 130
Molecular characterisation of human common fragile site FRA6E, a large genomic region spanning 9 Mb 128
Sviluppo e differenziamento muscolare nell'urodelo Ambystoma Mexicanum 128
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations. 126
Identification of putative cancer-related antisense transcripts in 6q21 and 6q27 125
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene. 125
Tumor and metastasis suppression by the human RNASET2 gene. 122
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 119
Regionalized expression of Ankirin Repeat Domain 1 gene is essential to regulate multiple aspects of sinoatrial development and ventricular trabeculation 119
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 106
RNASET2 is a non-cell autonomous human tumor suppressor 103
Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report 93
Recombinant HvRNASET2 protein induces a marked connective tissue remodelling in the invertebrate model Hirudo verbana 90
RNASET2 is the first ribonuclease of the Rh/T2/S family discovered in humans and displays unusual roles in tumor suppression. 75
The alarmin-like RNASET2 molecule exerts cell-autonomous and non-cell autonomous activities in prostate cancer models 72
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells 66
The human RNASET2 alarmin-like molecule differentially affects prostate cancer cells behavior in both cell autonomous and non-cell autonomous manners 62
The alarmin-like RNASET2 proteins impacts on prostate cancer (PCa) cell proliferation and inflammatory properties and shape macrophage polarization in a prostate cancer (PCa) in vivo model 59
Medicinal leeches: a promising source of cell lines with multiple biotechnological applications 56
Totale 6.460
Categoria #
all - tutte 24.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021421 0 0 0 0 0 64 32 46 93 32 73 81
2021/2022447 61 59 31 40 26 7 30 34 15 50 38 56
2022/2023710 64 55 46 89 44 133 7 116 91 16 32 17
2023/20241.050 145 150 142 176 215 102 15 6 32 16 16 35
2024/2025840 15 8 119 54 40 55 48 78 71 79 88 185
2025/20261.136 187 120 122 351 248 108 0 0 0 0 0 0
Totale 6.460